A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary Hypertension
A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary Hypertension
Not yet recruiting · NCT07613216 · Registry updated 2026-05-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary Hypertension | Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, Usual Interstitial Pneumonia, cardiovascular disorder, hypertensive disorder, idiopathic pulmonary fibrosis, immune system disorder, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, pulmonary fibrosis, pulmonary hypertension, pulmonary sarcoidosis, respiratory system disorder, sarcoidosis, vascular disorder | Not yet recruiting | Not stated | 2026-05-29 | NCT07613216 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cosmos Rx, Inc | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 791 |
| Sentara Norfolk General Hospital | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Pulmonary Disease Clinic, Sentara Norfolk Hospital | Norfolk | United States | 1 |